Home › Type 2 Diabetes › Illinois › Chicago

Pag-aaral pangklinika para sa Type 2 Diabetes sa Chicago, IL

19 pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Chicago (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Nagre-recruitPhase 3

Cedar Crosse Research Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07064473

A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo

Research Site, Chicago

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07024823

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Nagre-recruitPhase 3

Research Site, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07776509

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Nagre-recruitPhase 3

Cedar Crosse Research Center, Chicago
Northwestern University, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07595549

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Nagre-recruitPhase 3

Research Site, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07662109

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Nagre-recruitPhase 3

Research Site, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07784270

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Nagre-recruitPhase 2

Research by Design, LLC - Internal Medicine, Chicago

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07271186

Achieving Routine Intervention and Screening for Emotional Health

Nagre-recruit

University of Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06887049

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Nagre-recruitPhase 2

Charter Research - Chicago, Chicago

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07527650

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Nagre-recruitPhase 2

Chicago Clinical Research Institute, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT07296484

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Northwestern University, Chicago

Edad 55 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06112418

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Nagre-recruitPhase 2

Cedar-Crosse Research Center, Chicago

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07415954

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Nagre-recruitPhase 3

Research Site, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07662135

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Nagre-recruitPhase 3

University of Illinois at Chicago, Chicago

Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06739122

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Nagre-recruit

Northwestern University, Chicago

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07521475

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

Nagre-recruit

Northwestern University, Chicago

Edad 14 hanggang 75 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07579702

Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes

Nagre-recruitObservasyonal na pag-aaral

Illinois Institute of Technology, Chicago

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT07650682

Enhancing Diabetes Care: Exposome &Amp; Sensors

Nagre-recruitObservasyonal na pag-aaral

University of Illinois - Chicago, Chicago
University of Illinois College of Nursing, Chicago

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 25, 2025 · NCT06989008

My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

University of Illinois at Chicago, Chicago

Edad 21 hanggang 75 · Lahat ng kasarian · Na-update Mar 5, 2025 · NCT05208164

Pag-aaral para sa Type 2 Diabetes sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.